Skip to Main Content
Donate

This is a test.

Ovarian Cancer Canada and the Quebec-Clinical Research Organization in Cancer team up to improve access to vital resources

This is a test.

Advocacy in action: Making game-changing PARP Inhibitors accessible for women in Prince Edward Island

This is a test.

Canadian innovation in ovarian cancer research can save the lives of women in Canada and around the world

This is a test.

Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative

This is a test.

Clinical Trial: New biomarkers, improved treatment pathways

This is a test.

Research knows no bounds

This is a test.

Prize awarded to researcher whose ovarian cancer vaccines are in preclinical studies funded by Ovarian Cancer Canada

This is a test.

Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million

This is a test.

Harnessing the power of vaccines to treat ovarian cancer

This is a test.

Enabling research on rare forms of ovarian cancer